However, delayed Ab responses are more evident for the IgA anti-SARS-CoV-2 Abs generated by vaccination when compared to infection alone [20,35,36], supporting the need of the second vaccine dose in order to achieve efficient mucosal protection [15,37,38]. Here, DDX41 is linked to infection.